Publications
This folder holds the following references to publications, sorted by year and author.
There are 90 references in this bibliography folder.
Davies A (2008).
The Public Law of Government Contracts.
Oxford University Press, Oxford . (ISBN: 978-0-19-928739-0).
Dickenson D (2008).
Body Shopping: the Economy Fuelled by Flesh and Blood.
Oneworld, Oxford.
Gibbons S (2008).
From Principles to Practice: Implementing Genetic Database Governance.
Medical Law International, 9(2):111-130.
Kaye J (2008).
The Regulation of Human Genomics in the UK and the USA.
In: Genomic Medicine, ed. by R Kumar. Oxford University Press, Oxford, chap. , pp. .
Kaye J (2008).
The regulation of direct-to-consumer genetic tests.
Hum Mol Genet, 17(R2):R180-3.
Kaye J, and Gibbons S (2008).
Mapping the Regulatory Space for Genetic Databases and biobanking in England and Wales.
Medical Law International(9):2.
Savulescu J, and Goold I (2008).
Freezing eggs for lifestyle reasons.
Am J Bioeth, 8(6):32-5.
Zika E, Schulte In den Baumen T, Kaye J, Brand A, and Ibarreta D (2008).
Sample, data use and protection in biobanking in Europe: legal issues.
Pharmacogenomics, 9(6):773-81.
Boddington P (2007).
Bioethics and Social Reality - Edited by Matti Hayry, Tuija Takala and Peter Herrisone-Kelly.
Bioethics, 21(6):351-352.
Dickenson D (2007).
Property in the Body: Feminist Approaches`.
Cambridge University Press, Cambridge.
Gibbons S, and Kaye J (2007).
Governing Genetic Databases: Collection, Storage and Use.
King's Law Journal, 18:201-208.
Gibbons S, and Kaye J (2007).
GOVERNING GENETIC DATABASES: COLLECTION, STORAGE AND USE.
Kings Law J, 18(2):ukpmcpa1468.
Gregory M, Boddington P, Dimond R, Atkinson P, Clarke A, and Collins P (2007).
Communicating about haemophilia within the family: the importance of context and of experience.
Haemophilia, 13(2):189-98.
Kang KB, Rajanayagam MAS, van der Zypp A, and Majewski H (2007).
A role for cyclooxygenase in aging-related changes of beta-adrenoceptor-mediated relaxation in rat aortas.
Naunyn Schmiedebergs Arch Pharmacol, 375(4):273-81.
Kaye J, Hawkins N, and Taylor J (2007).
Patents and translational research in genomics.
Nat Biotechnol, 25(7):739-41.
Boddington P (2006).
Commentary 1. 'Telling the truth about genomics': hype and hope.
Commun Med, 3(1):93-4; discussion 99-100.
Boddington P, and Hogben S (2006).
Working up policy: the use of specific disease exemplars in formulating general principles governing childhood genetic testing.
Health Care Anal, 14(1):1-13.
Dickenson D (2006).
Gender and ethics committees: where's the 'different voice'?
Bioethics, 20(3):115-24.
Dickenson D (2006).
The Lady Vanishes: What's Missing From the Stem Cell Debate.
Journal of Bioethical Inquiry, 3:43-54.
Goold I, Pearn A, Bettiol S, and Ballantyne A (2006).
Quality and safety of genetic testing in Australia and New Zealand: a review of the current regulatory framework.
Aust New Zealand Health Policy, 3:13.
Hogben S, and Boddington P (2006).
The rhetorical construction of ethical positions: policy recommendations for nontherapeutic genetic testing in childhood.
Commun Med, 3(2):135-46.
Kaye J (2006).
Do we need a uniform regulatory system for biobanks across Europe?
Eur J Hum Genet, 14(2):245-8.
Lucassen A, and Kaye J (2006).
Genetic testing without consent: the implications of the new Human Tissue Act 2004.
J Med Ethics, 32(12):690-2.
Martin P, and Morrison M (2006).
Realising the Potential of Genomic Medicine.
Royal Pharmaceutical Society of Great Britain, London.
Raisanen U, Bekkers MJ, Boddington P, Sarangi S, and Clarke A (2006).
The causation of disease - the practical and ethical consequences of competing explanations.
Med Health Care Philos, 9(3):293-306.
Newly released is a report of the Expert Group on Dealing with Ethical and Regulatory Challenges of International Biobank Research. It is entitled Biobanks for Europe - A challenge for governance. Dr Jane Kaye, HeLEX Director, was the rapporteur. (Update: 
